ArticleAntimicrobial agents and chemotherapy2024

Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.

Julie M Strizki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.